JP2022524083A5 - - Google Patents
Info
- Publication number
- JP2022524083A5 JP2022524083A5 JP2021553012A JP2021553012A JP2022524083A5 JP 2022524083 A5 JP2022524083 A5 JP 2022524083A5 JP 2021553012 A JP2021553012 A JP 2021553012A JP 2021553012 A JP2021553012 A JP 2021553012A JP 2022524083 A5 JP2022524083 A5 JP 2022524083A5
- Authority
- JP
- Japan
- Prior art keywords
- therapeutically active
- active biological
- individual
- biological agents
- drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024195155A JP2025020335A (ja) | 2019-03-08 | 2024-11-07 | 薬物に依存しない患者固有の投薬レジメンのためのシステムおよび方法 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962815825P | 2019-03-08 | 2019-03-08 | |
| US62/815,825 | 2019-03-08 | ||
| USPCT/US2019/028750 | 2019-04-23 | ||
| US16/391,950 | 2019-04-23 | ||
| PCT/US2019/028750 WO2019209845A1 (en) | 2018-04-23 | 2019-04-23 | Systems and methods for modifying adaptive dosing regimens |
| US16/391,950 US20190326002A1 (en) | 2018-04-23 | 2019-04-23 | Systems and methods for modifying adaptive dosing regimens |
| PCT/US2020/021742 WO2020185699A1 (en) | 2019-03-08 | 2020-03-09 | Systems and methods for drug-agnostic patient-specific dosing regimens |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024195155A Division JP2025020335A (ja) | 2019-03-08 | 2024-11-07 | 薬物に依存しない患者固有の投薬レジメンのためのシステムおよび方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022524083A JP2022524083A (ja) | 2022-04-27 |
| JP2022524083A5 true JP2022524083A5 (https=) | 2023-03-17 |
| JP7618239B2 JP7618239B2 (ja) | 2025-01-21 |
Family
ID=72426742
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021553012A Active JP7618239B2 (ja) | 2019-03-08 | 2020-03-09 | 薬物に依存しない患者固有の投薬レジメンのためのシステムおよび方法 |
| JP2024195155A Pending JP2025020335A (ja) | 2019-03-08 | 2024-11-07 | 薬物に依存しない患者固有の投薬レジメンのためのシステムおよび方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024195155A Pending JP2025020335A (ja) | 2019-03-08 | 2024-11-07 | 薬物に依存しない患者固有の投薬レジメンのためのシステムおよび方法 |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP3935639A1 (https=) |
| JP (2) | JP7618239B2 (https=) |
| KR (1) | KR102839034B1 (https=) |
| AU (2) | AU2020239014A1 (https=) |
| CA (1) | CA3132823A1 (https=) |
| IL (1) | IL286145A (https=) |
| SG (1) | SG11202109704UA (https=) |
| WO (1) | WO2020185699A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12064664B2 (en) | 2020-11-10 | 2024-08-20 | Willowview Consulting, Llc | Method and system for dynamically transforming user health and exercise-related data into visual, audio, textual, and physical data representations |
| US20220199266A1 (en) * | 2020-12-10 | 2022-06-23 | DataRobot, Inc. | Systems and methods for using machine learning with epidemiological modeling |
| CN113643785B (zh) * | 2021-07-22 | 2023-09-01 | 海南大学 | 基于dikw图谱的疫苗接种浓度确认方法 |
| CN114765076A (zh) * | 2022-04-18 | 2022-07-19 | 柳州市妇幼保健院 | 新生儿个体化氟康唑给药量计算方法及给药方案推荐系统 |
| KR102834065B1 (ko) * | 2022-09-22 | 2025-07-16 | 서울대학교산학협력단 | 약동학적 변화량 예측 장치 및 방법 |
| CN116453669B (zh) * | 2023-06-14 | 2023-08-25 | 武汉大学中南医院 | 一种基于大数据的护理预测方法及装置 |
| WO2025006459A1 (en) * | 2023-06-29 | 2025-01-02 | Prxcision, Inc. | Machine learning for real-time decision support |
| CN118016237A (zh) * | 2024-01-22 | 2024-05-10 | 南栖仙策(南京)高新技术有限公司 | 给药剂量确定方法、装置、电子设备及存储介质 |
| CN120448609B (zh) * | 2025-07-11 | 2025-09-16 | 上海斯丹姆医药开发有限责任公司 | 一种流感疫苗临床试验中的数据可视化方法及系统 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1227302A (en) * | 2000-09-15 | 2002-03-26 | Virco Nv | System and method for optimizing drug therapy for the treatment of diseases |
| EP2562664B1 (en) | 2007-06-27 | 2020-11-25 | Roche Diabetes Care GmbH | System for determining an insulin delivery and communicating a dose in automated pancreas software |
| WO2011082421A1 (en) | 2010-01-04 | 2011-07-07 | Mayo Foundation For Medical Education And Research | Erythropoietic stimulating agent (esa) dosage determination |
| JP5970449B2 (ja) | 2010-04-07 | 2016-08-17 | ノヴァディスカバリー | 処置成果を予測するためのコンピュータベースシステム |
| SG10201907682RA (en) | 2012-10-05 | 2019-10-30 | Mould Diane | System and method for providing patient-specific dosing as a function of mathematical models |
| CA2988724C (en) | 2015-04-09 | 2023-10-10 | Diane R. Mould | Systems and methods for patient-specific dosing |
-
2020
- 2020-03-09 KR KR1020217032413A patent/KR102839034B1/ko active Active
- 2020-03-09 AU AU2020239014A patent/AU2020239014A1/en not_active Abandoned
- 2020-03-09 JP JP2021553012A patent/JP7618239B2/ja active Active
- 2020-03-09 CA CA3132823A patent/CA3132823A1/en active Pending
- 2020-03-09 EP EP20714457.7A patent/EP3935639A1/en active Pending
- 2020-03-09 SG SG11202109704U patent/SG11202109704UA/en unknown
- 2020-03-09 WO PCT/US2020/021742 patent/WO2020185699A1/en not_active Ceased
-
2021
- 2021-09-05 IL IL286145A patent/IL286145A/en unknown
-
2024
- 2024-11-07 JP JP2024195155A patent/JP2025020335A/ja active Pending
-
2025
- 2025-12-03 AU AU2025275175A patent/AU2025275175A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022524083A5 (https=) | ||
| Levy et al. | Effect of moderate hypothermia vs normothermia on 30-day mortality in patients with cardiogenic shock receiving venoarterial extracorporeal membrane oxygenation: a randomized clinical trial | |
| Andrade-Junior et al. | Skeletal muscle wasting and function impairment in intensive care patients with severe COVID-19 | |
| Garibaldi et al. | Comparison of time to clinical improvement with vs without remdesivir treatment in hospitalized patients with COVID-19 | |
| Najjar et al. | Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial | |
| Laupacis et al. | The use of generic and specific quality-of-life measures in hemodialysis patients treated with erythropoietin | |
| Berendes et al. | Reversible cardiac sympathectomy by high thoracic epidural anesthesia improves regional left ventricular function in patients undergoing coronary artery bypass grafting: a randomized trial | |
| Mulherin et al. | Clinical improvement and radiological deterioration in rheumatoid arthritis: evidence that the pathogenesis of synovial inflammation and articular erosion may differ | |
| Renaud et al. | Sparing of muscle mass and function by passive loading in an experimental intensive care unit model | |
| Wu et al. | Systematic review of motor function scales and patient-reported outcomes in spinal muscular atrophy | |
| CN102171240A (zh) | 治疗炎症的方法 | |
| JP4560081B2 (ja) | 薬剤の計時投薬の改良された方法 | |
| CN111888463B (zh) | 用于治疗抑郁症的胸腺素β4药物制剂与制备方法及其应用 | |
| Zhao et al. | Propofol and sevoflurane combined with remifentanil on the pain index, inflammatory factors and postoperative cognitive function of spine fracture patients | |
| Iliopoulou et al. | Time-dependent and independent effects of thyroid hormone administration following myocardial infarction in rats | |
| Magréault et al. | Dosing and route of administration of clindamycin given in combination with rifampicin | |
| Chen et al. | Expression data analysis to identify key target genes in visceral fat tissue associated with obstructive sleep apnea. | |
| US20080249020A1 (en) | Human Growth Hormone Treatment Methods | |
| JP2024527230A5 (https=) | ||
| WO2023102970A1 (zh) | 甲状旁腺激素在制备治疗男性抑郁症的药物或保健品中的应用 | |
| Kang et al. | Up-regulation of peroxisome proliferator-activated receptor γ in perennial allergic rhinitis | |
| Linfield et al. | Impact of Apitegromab on Motor Function in Spinal Muscular Atrophy | |
| Johannsen et al. | O-247 The intrafollicular inflammatory response during ovulation in women is most likely controlled by high concentrations of active cortisol being synthesized shortly before follicular rupture | |
| Otimenyin | Dosage regimen | |
| Jose et al. | Convalescent plasma therapy: A novel approach to a novel coronavirus |